A Hybrid Insulin Epitope Maintains High 2D Affinity for Diabetogenic T Cells in the Periphery.
Beta-cell antigen recognition by autoreactive T cells is essential in type I diabetes (T1D) pathogenesis. Recently, insulin hybrid peptides (HIPs) were identified as strong agonists for CD4 diabetogenic T cells. Here, using BDC2.5 transgenic and NOD mice, we investigated T cell recognition of the HIP2.5 epitope, which is a fusion of insulin C-peptide and Chromogranin A (ChgA) fragments, and compared it with the WE14 and ChgA29-42 epitopes. We measured in situ 2D affinity on individual live T cells from thymus, spleen, pancreatic lymph nodes, and islets prior to and post diabetes. Although preselection BDC2.5 thymocytes possess higher affinity than splenic BDC2.5 T cells for all three epitopes, peripheral splenic T cells maintained high affinity only to the HIP2.5 epitope. In polyclonal NOD mice, a high frequency (∼40%) of HIP2.5-specific islet T cells were identified at both prediabetic and diabetic stages comprised by two-distinct high and low affinity populations that differed in affinity by 100-fold. This high frequency of high and low affinity HIP2.5 T cells in the islets potentially represents a major risk factor in diabetes pathogenesis.